Table 4 Demographic characteristics of the subjects in clinical study II.
From: Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
Characteristics | AR68 5 mg/ml (n = 22) | Placebo (n = 21) | |
|---|---|---|---|
n (%) | n (%) | ||
Sex | Male | 9 (40.90) | 10 (47.62) |
Female | 13 (50.10) | 11 (52.38) | |
Age | Mean ± SD | 44.77 ± 10.88 | 46.48 ± 7.93 |
|---|---|---|---|
Median | 49.50 | 48.00 | |
Min, Max | 22.00, 54.00 | 25.00, 54.00 | |
20 < | 0 (0.00) | 0 (0.00) | |
20–29 | 4 (18.18) | 2 (9.52) | |
30–39 | 1 (4.55) | – | |
40–49 | 6 (27.27) | 9 (42.86) | |
≥ 50 | 11 (50.00) | 10 (47.62) |
